The frequency and severity of cardiac involvement in myotonic dystrophy type 2 (DM2): Long-term outcomes

International Journal of Cardiology

Volumn 168, Issue 2, 2013, Pages 1147-1153

  Sansone, V A ^a   Brigonzi, E ^a   Schoser, B ^b   Villani, S ^c   Gaeta, M ^c   De Ambroggi, G ^d   Bandera, F ^d   De Ambroggi, L ^d   Meola, G ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^c UNIVERSITY OF PAVIA   (Italy)

^d IRCCS POLICLINICO SAN DONATO   (Italy)

Author keywords

Cardiac arrhythmias; Myotonic dystrophy type 1; Myotonic dystrophy type 2; Sudden cardiac death

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL ASSESSMENT; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE DURATION; DISEASE SEVERITY; ELECTROCARDIOGRAM; FEMALE; FOLLOW UP; GERMANY; HEART DISEASE; HEART FUNCTION TEST; HOLTER MONITORING; HUMAN; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; ITALY; MAJOR CLINICAL STUDY; MALE; MUSCLE STRENGTH; MUSCLE WEAKNESS; MYOTONIC DYSTROPHY; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; TREATMENT OUTCOME; TWO DIMENSIONAL ECHOCARDIOGRAPHY;

CARDIAC ARRHYTHMIAS; MYOTONIC DYSTROPHY TYPE 1; MYOTONIC DYSTROPHY TYPE 2; SUDDEN CARDIAC DEATH;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ARRHYTHMIAS, CARDIAC; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; GERMANY; HUMANS; ITALY; MALE; MIDDLE AGED; MUSCLE STRENGTH; MUSCLE WEAKNESS; MYOTONIC DISORDERS; SEVERITY OF ILLNESS INDEX; TIME FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84885315415     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2012.11.076     Document Type: Article

References (35)

1. Harper PS. Myotonic dystrophy. London: W.B. Saunders; 2001.
2. Mathieu J, Allard P, Potvin L, Prevost C, Begin P. A 10-year study of mortality in a cohort of patients with myotonic dystrophy. Neurology 1999;52:1658-62.
3. Pelargonio G, Dello Russo A, Sanna T, De Martino G, Bellocci F. Myotonic dystrophy and the heart. Heart 2002;88:665-70.
4. Groh WJ, Groh MR, Saha C, et al. Electrocardiographic abnormalities and sudden death in myotonic dystrophy type 1. N Engl J Med 2008;358:2688-97.
5. Lazarus A, Varin J, Ounnoughene Z, et al. Relationship among electrophysiological findings and clinical status, heart function and extent of DNA mutation in myotonic dystrophy. Circulation 1999;99:1041-6.
6. Dello Russo A, Pace M, Bellocci F. Sudden death in myotonic dystrophy. N Engl J Med 2008;359:1626.
7. Lazarus A, Varin J, Babuty D, Anselme F, Coste J, Duboc D. Long-termfollow-up of arrhythmias in patientswithmyotonic dystrophy treated by pacing: amulti-centre diagnostic pacemaker study. J Am Coll Cardiol 2002;40:1645-52.
8. Hermans MCE, Pinto YM. Sudden death in myotonic dystrophy. N Engl J Med 2010;359:1626-9.
9. de Die-Smulders CE, Howeler CJ, Thijs C, et al. Age and causes of death in adult-onset myotonic dystrophy. Brain 1998;121:1557-63.
10. Bhakta D, Lowe MR, Groh WJ. The prevalence of structural heart abnormalities in myotonic dystrophy type 1. Am Heart J 2004;147:224-7.
11. Cudia P, Bernasconi P, Chiodelli R, et al. Risk of arrhythmia in type I myotonic dystrophy: the role of clinical and genetic variables. J Neurol Neurosurg Psychiatry 2009;80:790-3.
12. Lindqvist P, Morner S, Olofsson BO, et al. Ventricular dysfunction in type 1myotonic dystrophy: electrical, mechanical, or both? Int J Cardiol 2010;143:378-84.
13. Bhakta D, Groh MR, Shen C, Pascuzzi RM, Groh WJ. Increased mortality with left ventricular systolic dysfunction and heart failure in adults with myotonic dystrophy type 1. Am Heart J 2010;160:1137-41.
14. Magrì D, Piccirillo G, Bucci E, et al. Increased temporal dispersion of myocardial repolarization in myotonic dystrophy type 1: beyond the cardiac conduction system. Int J Cardiol 2012;156:259-64.
15. Mammarella A, Paradiso M, Antonini G, et al. Natural history of cardiac involvement in myotonic dystrophy (Steinert's disease): a 13-year follow-up study. Adv Ther 2000;17:238-51.
16. Dello Russo A, Mangiola F, Della Bella P, et al. Risk of arrhythmias in myotonic dystrophy: trial design of the RAMYD study. J Cardiovasc Med (Hagerstown) 2009;10:51-8.
17. Wahbi K, Meune C, Porcher R, et al. Electrophysiological study with prophylactic pacing and survival in adults with myotonic dystrophy and conduction system disease. JAMA 2012;307:1292-301.
18. Breton R, Matthieu J. Usefulness of clinical and electrocardiographic data for predicting adverse cardiac events in patientswith myotonic dystrophy. Can J Cardiol 2009;25:e23-7.
19. Mörner S, Lindqvist P, Mellberg C, et al. Profound cardiac conduction delay predicts mortality in myotonic dystrophy type 1. J Intern Med 2010;268:59-65.
20. Nazarian S, Wagner KR, Caffo BS, Tomaselli GF. Clinical predictors of conduction disease progression in type I myotonic muscular dystrophy. Pacing Clin Electrophysiol 2011;34:171-6.
21. Petri H, Vissing J, Witting N, Bundgaard H, Koøber L. Cardiac manifestations of myotonic dystrophy type 1. Int J Cardiol 2011;160:82-8.
22. Meola G, Sansone V, Marinou K, et al. Proximal myotonic myopathy: a syndrome with a favourable prognosis? J Neurol Sci 2002;193:89-96.
23. Day JW, Ricker K, Jacobsen JF, et al. Myotonic dystrophy type 2: molecular, diagnostic and clinical spectrum. Neurology 2003;60:657-64.
24. Wahbi K, Meune C, Bécane HM, et al. Left ventricular dysfunction and cardiac arrhythmias are frequent in type 2 myotonic dystrophy: a case control study. Neuromuscul Disord 2009;19:468-72.
25. Schoser BG, Ricker K, Schneider-Gold C, et al. Sudden cardiac death in myotonic dystrophy type 2. Neurology 2004;63:2402-4.
26. Ranum LP, Day JW. Myotonic dystrophy: clinical and molecular parallels between myotonic dystrophy type 1 and type 2. Curr Neurol Neurosci Rep 2002;2:465-70.
27. Ha AH, Tarnopolsky MA, Bergstra TG, Nair GM, Al-Qubbany A, Healey JS. Predictors of atrio-ventricular conduction disease, long-term outcomes in patients with myotonic dystrophy types I and II. PACE 2012;35:1262-9.
28. Mathieu J, Boivin H, Meunier D, Gaudreault M, Begin P. Assessment of a disease-specific muscular impairment rating scale in myotonic dystrophy. Neurology 2001;56:336-40.
29. Kamsteeg EJ, Kress W, Catalli C, et al. Best practice guidelines and recommendations on the molecular diagnosis of myotonic dystrophy types 1 and 2. Eur J Hum Genet 2012;20:1203-8.
30. Udd B, Meola G, Krahe, et al. Myotonic dystrophy type 2 (DM2) and related disorders. Report of the 180th ENMC Workshop including guidelines on diagnostic and management. 3-5 December 2010, Naarden, The Netherlands. Neuromuscul Disord 2011;21:443-50.
31. Epstein AE, DiMarco JP, Ellenbogen KA, et al. ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia devices): Developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons. Circulation 2008;117:e350-408.
32. Lang RM, Bierig M, Devereux RB, et al. ASE Committee Recommendations. Recommendations for Chamber Quantification: a Report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, Developed in Conjunction with the European Association of Echocardiography, a Branch of the European Society of Cardiology. J Am Soc Echocardiogr 2005;18:1440-63.
33. Sansone VA, De Ambroggi G, Zanolini A, et al. Long-term follow-up free of ventricular fibrillation recurrence after resuscitated cardiac arrest in a myotonic dystrophy type 1 patient. Europace 2009;11:1243-4.
34. Vihola A, Bachinski LL, Sirito M, et al. Differences in aberrant expression and splicing of sarcomeric proteins in the myotonic dystrophies DM1 and DM2. Acta Neuropathol 2010;119:465-79.
35. Schoser B, Timchenko L. Myotonic dystrophies 1 and 2: complex diseases with complex mechanisms. Curr Genomics 2010;11:77-90.